Terminated PHASE2 INTERVENTIONAL 3-arm NCT01935622

Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy (DOXY-HF)

Phase II Study of Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy

Sponsor: Virginia Commonwealth University

Conditions Non-ischemic Cardiomyopathy Systolic Heart Failure (NYHA II-III)

Updated 9 times since 2017 Last updated: Aug 19, 2014 Started: Jul 31, 2012 Primary completion: Jun 30, 2014 Completion: Jun 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

End of funding

Other terminated trials from Virginia Commonwealth University

See all terminations from Virginia Commonwealth University

A PHASE2 clinical study on Non-ischemic Cardiomyopathy and Systolic Heart Failure (NYHA II-III), this trial is terminated or withdrawn. The trial is conducted by Virginia Commonwealth University and has accumulated 9 data snapshots since 2012. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2023 — Jul 2024 [monthly]

Terminated PHASE2
Dec 2022 — Jan 2023 [monthly]

Terminated PHASE2
Dec 2021 — Dec 2022 [monthly]

Terminated PHASE2

▶ Show 4 earlier versions

Jan 2021 — Dec 2021 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE2
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE2

First recorded

Jul 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Virginia Commonwealth University

Data source: Virginia Commonwealth University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Richmond, United States